AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,314,000 | +55.0% | 67,157 | -24.8% | 0.00% | +100.0% |
| Q2 2020 | $1,493,000 | +33.3% | 89,327 | +15.0% | 0.00% | 0.0% |
| Q1 2020 | $1,120,000 | -51.4% | 77,674 | +12.8% | 0.00% | -50.0% |
| Q4 2019 | $2,304,000 | +72.2% | 68,831 | +7.7% | 0.00% | +100.0% |
| Q3 2019 | $1,338,000 | +1.3% | 63,890 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $1,321,000 | +2.9% | 63,428 | +10.4% | 0.00% | 0.0% |
| Q1 2019 | $1,284,000 | -7.4% | 57,453 | -0.9% | 0.00% | -33.3% |
| Q4 2018 | $1,386,000 | +30.1% | 57,947 | +48.5% | 0.00% | +50.0% |
| Q3 2018 | $1,065,000 | -5.1% | 39,031 | -6.5% | 0.00% | 0.0% |
| Q2 2018 | $1,122,000 | +5.6% | 41,731 | +25.0% | 0.00% | 0.0% |
| Q1 2018 | $1,063,000 | -17.0% | 33,383 | -1.4% | 0.00% | -33.3% |
| Q4 2017 | $1,281,000 | +28.7% | 33,863 | -15.7% | 0.00% | +50.0% |
| Q3 2017 | $995,000 | +22.4% | 40,150 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $813,000 | +26.2% | 39,560 | +33.5% | 0.00% | 0.0% |
| Q1 2017 | $644,000 | +9.9% | 29,632 | +3.5% | 0.00% | +100.0% |
| Q4 2016 | $586,000 | +52.6% | 28,637 | +11.8% | 0.00% | 0.0% |
| Q3 2016 | $384,000 | +67.7% | 25,607 | +20.8% | 0.00% | 0.0% |
| Q2 2016 | $229,000 | +57.9% | 21,200 | +98.5% | 0.00% | – |
| Q1 2016 | $145,000 | – | 10,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|